CBC Group
Sam Liao has a diverse work experience in the healthcare and research fields. Sam started their career as an Assistant Researcher at the Institute of Neuroscience in 2010, followed by a position at the Temasek Life Sciences Laboratory in 2011. In 2012, they joined IQVIA as an Engagement Manager, where they specialized in healthcare management consulting and worked with various multinational and local companies. Sam had expertise in areas such as new product launch, pricing and access, and clinical assessment. In 2018, they became a Vice President at aihc capital, a healthcare specialty hedge fund, where they focused on the pharmaceutical, biotech, and medtech sectors. Currently, they hold the position of Vice President at CBC Group, starting in 2021.
Sam Liao attended Shanghai Jiao Tong University from 2006 to 2010, earning a Bachelor of Science degree in Biotechnology.
This person is not in any offices
CBC Group
Headquartered in Singapore, CBC Group is Asia's largest healthcare-dedicated asset management firm, focused on platform-building, buyout, private credit, venture, and real estate, across the healthcare space, including pharmaceutical, biotech, medical technology, and healthcare services. We are committed to creating lasting value by integrating global innovations and talents. Partnering with the world's top entrepreneurs and scientists, our unique "investor-operator" approach has empowered leading healthcare companies to widen access to affordable medical care, catalyse innovations, and improve efficiency in fulfilling unmet medical needs worldwide.